InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
58,007.51
(
2.40%
)
Post# of 376163
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

reddymade

Send PM Follow Ignore
Followers 2
Posts 438
Boards Moderated 0
Alias Born 03/23/2005

reddymade

Re: None

Sunday, 11/12/2006 1:31:24 PM

Sunday, November 12, 2006 1:31:24 PM

Post# of 376163
Amgen (AMGN) on Sunday revealed that Enbrel is the first biologic with published data to show improvements in multiple measures of efficacy that were sustained in rheumatoid arthritis or RA patients completing up to nine years of therapy. According to the company, the data in Rheumatoid Arthritis suggested that Enbrel is both effective and safe in long-term use.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up